Charles River Laboratories Announces CFO Transition
2025-09-16SEC Filing 8-K (0000950103-25-011676)
Charles River Laboratories International, Inc. announced the resignation of Flavia H. Pease, Corporate Executive Vice President and Chief Financial Officer (CFO), effective September 29, 2025. Pease's departure is not due to any disagreements with the company. Michael G. Knell, Corporate Senior Vice President and Chief Accounting Officer, has been appointed as the interim CFO until a permanent successor is named. Knell has been with the company since 2017 and has extensive experience in finance and accounting. The company has commenced a comprehensive search for a new CFO. Charles River reaffirmed its 2025 financial guidance for revenue and non-GAAP earnings per share.
Tickers mentioned in this filing:CRL
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1100682/0000950103-25-011676.txt